By Dr Jennifer Wen Ying Lim

Journal articles

Lim J; Chin V; Fairfax K; Moutinho C; Suan D; Ji H; Powell JE, 2023, 'Transitioning single-cell genomics into the clinic', Nature Reviews Genetics, 24, pp. 573 - 584, http://dx.doi.org/10.1038/s41576-023-00613-w

Li M; Chan DL; Tapia Rico G; Cehic G; Lawrence B; Wyld D; Pattison DA; Kong G; Hicks R; Michael M; Kiberu AD; Lim J; Clifton-Bligh R; Tsang V; Roach PJ; Leyden J; Diakos CI; Price TJ; Pavlakis N, 2023, 'Australasian Consensus Statement on the Identification, Prevention, and Management of Hormonal Crises in Patients with Neuroendocrine Neoplasms Undergoing Peptide Receptor Radionuclide Therapy', Neuroendocrinology, 113, pp. 281 - 288, http://dx.doi.org/10.1159/000526848

Lim J; Akbar Ali S; Prawira A; Sim HW, 2023, 'Impact of travel distance on outcomes for clinical trial patients: the Kinghorn Cancer Centre experience', Internal Medicine Journal, 53, pp. 242 - 249, http://dx.doi.org/10.1111/imj.15561

Lim J; Murphy A; Wong S; Nagrial A; Karikios D; Daneshvar D; McCloy R; Steinmann AM; O'Toole S; Chin V, 2022, 'Activin-A, Growth Differentiation Factor-11 and Transforming Growth Factor-β as predictive biomarkers for platinum chemotherapy in advanced non-small cell lung cancer', Cancer Treatment and Research Communications, 32, http://dx.doi.org/10.1016/j.ctarc.2022.100576

Lomax AJ; Lim J; Cheng R; Sweeting A; Lowe P; McGill N; Shackel N; Chua EL; McNeil C, 2018, 'Immune Toxicity with Checkpoint Inhibition for Metastatic Melanoma: Case Series and Clinical Management', Journal of Skin Cancer, 2018, http://dx.doi.org/10.1155/2018/9602540

Lim J; Lomax AJ; McNeil C; Harrisberg B, 2018, 'Uveitis and Papillitis in the Setting of Dabrafenib and Trametinib Therapy for Metastatic Melanoma: A Case Report', OCULAR IMMUNOLOGY AND INFLAMMATION, 26, pp. 628 - 631, http://dx.doi.org/10.1080/09273948.2016.1246666

Back to profile page